Name:
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)
Type:
AKA:
N/A
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) image
Synthetic substance, no natural derivative
IUPAC Logo
Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine) image
Flualprazolam, a benzodiazepine, was developed in the 2010s. It is known for its anxiolytic and sedative properties. Its history includes its use in research and its regulatory status due to potential abuse and dependence issues.
Synthetic Substances Image
Flualprazolam, a benzodiazepine, provides anxiolytic and sedative effects. It causes drowsiness, reduced heart rate, and muscle relaxation. Short-term use is effective for anxiety relief, but long-term use may result in dependence and cognitive issues. Overdose risks include severe sedation, respiratory depression, and possible death. Safe use involves careful dosing and monitoring. Recent research highlights its effectiveness and the potential for misuse.
N/A
N/A
N/A
Flualprazolam is a designer benzodiazepine, part of the new psychoactive substances (NPS) group, known for its potent anxiolytic and sedative effects. Designer benzodiazepines like flualprazolam have emerged as alternatives to prescription medications, often sold online and used recreationally. Their rise reflects contemporary issues with mental health treatment, access to medications, and regulatory challenges. Historically, benzodiazepines have been used to manage anxiety and sleep disorders, with a complex legacy of therapeutic benefits and potential for misuse. The cultural significance of flualprazolam lies in its role within the broader context of designer drugs, public health, and the ongoing evolution of substance use and regulation.
N/A